Skip to main content
. Author manuscript; available in PMC: 2021 Oct 22.
Published in final edited form as: Adv Funct Mater. 2020 Sep 6;30(43):2004307. doi: 10.1002/adfm.202004307

Figure 1.

Figure 1.

Scheme illustrating the microfluidic generation of drug-releasing MAP (drugMAP) scaffolds for MI therapy. A) Microfluidic generation of drugMAP building blocks by encapsulating drug/NPs into μGel beads to generate drug/NPs-μGel beads in a microfluidic device. The hydrogels are formed by crosslinking pregel solutions via thiol-ene reactions to encapsulate NPs in the gel mesh. B) Injection of cardiac drugMAP scaffolds for MI therapy. Via delivery of specific drugs, the cardiac drugMAP scaffolds endow pleiotropic benefits for heart repair.